Table 3. Abbreviated Evidence Table of Effects of Fluoride Varnish on Primary Teeth
| Study, year |
Country |
Design |
Age at baseline |
Fluoride interventions |
Other F exposure |
Blinding |
Attrition, % |
Sample size, n |
% Reductiona, index
used |
NNT |
| Experiment |
Control |
| Holm, 197939 |
Sweden |
RCT, 2 y, alternate assignment |
3.0 |
2.2% F Duraphat®
2/y |
71% F dentifrice,
27% F tabs |
Patients |
10 |
113 |
112 |
44**, defs |
1.2 |
| Grodzka, 198240 |
Poland |
Comparison schools, 2 y, assignment unclear |
3.5 |
2.2% F Duraphat®
2/y |
"low" F exposure, no professional F application |
None |
20 |
100 |
148 |
5, dmfs1 |
|
| Frostell, 199141 |
Sweden |
RCT, 2 y |
4.0 |
2.2% F Duraphat® w/wo invert sugar 2/y |
"most" use F dentifrice, "occasional" use of F supplements
and mouth rinse |
Examiners |
Not reported |
26 (sucrose)
18 (invert)
113 (neither) |
37
33
93 |
+31, dmfs2 +50, dmfs2 30, dmfs2 37**, dmfs1 |
1.5 |
| Twetman, 199642 |
Sweden |
Comm trial, 2 y, public clinics matched on SES |
4.5 |
0.1% F Fluor Protector® 2/y |
0.1 ppm F in water,
95% on F dentifrice, "a few" given F supplements |
None |
2 |
374 |
442 |
30*, dfs |
4.3 |
| Petersson, 199843 |
Sweden |
Comm trial, 2 y, public clinics matched on specified criteria |
4.5 |
0.1% F Fluor Protector® 2/y |
10% with 1.2 ppm in water, 90% use F dentifrice |
None |
19 |
1,916 |
2,245 |
6, dfs |
NR |
| Autio-Gold, 200144 |
United States |
RCT, 0.75 y |
3-5 |
2.2% F Duraphat® |
0.8 ppm F in water |
Patients |
22 |
83 |
59 |
63*, dmfs1
67**, dmfs2 |
0.8 |
| aDifferences not significant unless otherwise
noted.
*Different from control at P < 0.05.
**Different from control at P < 0.01.
Note: Comm indicates community; defs, decayed, extracted,
and filled primary tooth surfaces; dfs, decayed, filled primary tooth surfaces;
dmfs1, decayed, missing, and filled primary tooth surfaces, incipient
lesions excluded; dmfs2, decayed, missing, and filled primary
tooth surfaces, incipient lesions included; F, fluoride; NNT, number needed
to treat; ppm, parts per million; RCT, randomized controlled trial; SES,
socioeconomic status; w/wo, with or without.
|
Return to Document
|